Cinnamic Alcohol

Cinnamic Alcohol

SCHEMBL891462

OC/C=C\c1ccccc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAM P19021 1/20 0.58
IDO1 P14902 2/20 0.52
MAOB P27338 2/20 0.50
ALDH1A1 P00352 2/20 0.50
RECQL P46063 2/20 0.50
CYP3A4 P08684 1/20 0.50
HTR2A P28223 3/20 0.48
HDAC3 O15379 1/20 0.46
TNKS O95271 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HCAR2 Q8TDS4 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
TNKS2 Q9H2K2 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cinnamic Alcohol SCHEMBL39220 1.00 PAM (0.58) PAMIDO1MAOBALDH1A1RECQL
Cinnamic Alcohol SCHEMBL28583889 1.00 PAM (0.58) PAMIDO1MAOBALDH1A1RECQL
Cinnamic Alcohol SCHEMBL4175503 1.00 PAM (0.58) PAMIDO1MAOBALDH1A1RECQL
Cinnamic Alcohol SCHEMBL39219 1.00 PAM (0.58) PAMIDO1MAOBALDH1A1RECQL
Cinnamic Alcohol SCHEMBL28671092 0.97 PAM (0.56) PAMIDO1MAOBALDH1A1RECQL
Cinnamic Alcohol SCHEMBL28671087 0.97 PAM (0.56) PAMIDO1MAOBALDH1A1RECQL
Biphenyl SCHEMBL21402588 0.93 PAM (0.52) PAMIDO1MAOBALDH1A1RECQL
Biphenyl SCHEMBL21402589 0.93 PAM (0.52) PAMIDO1MAOBALDH1A1RECQL
Cinnamic Alcohol SCHEMBL901221 0.93 PAM (0.52) PAMIDO1MAOBALDH1A1RECQL
Cinnamic Alcohol SCHEMBL7139687 0.91 IDO1 (0.50) PAMIDO1ALDH1A1RECQLCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 446 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4257663-A1 FOOD CONTACT SURFACE SANITIZING LIQUID The Procter & Gamble Company (US) 2023-10-11 EP claimed
US-11002716-B2 Method of resolving defined known or suspected allergens in a complex mixture of perfume ingredients, and compositions GIVAUDAN SA (CH) 2021-05-11 US claimed
CN-111978142-A Method for isomerizing cis-olefin into trans-olefin 厦门大学 2020-11-24 CN claimed
EP-3465198-B1 METHOD OF RESOLVING ALLERGENS IN PERFUME INGREDIENTS GIVAUDAN SA (CH) 2020-08-19 EP claimed
EP-3218425-B1 SILICONE COMPOUNDS PROCTER & GAMBLE (US) 2020-05-13 EP claimed
US-20190145942-A1 Improvements in or Relating to Organic Compounds GIVAUDAN SA (CH) 2019-05-16 US claimed
EP-3465198-A1 METHOD OF RESOLVING ALLERGENS IN PERFUME INGREDIENTS Givaudan S.A. (CH) 2019-04-10 EP claimed
EP-3349861-A1 PERFUME COMPOSITION COMPRISING FRAGRANCE MODULATOR COMPOUNDS AND SILICIC ACID ESTERS FOR INCREASING AND PROLONGING THE INTENSITY OF FRAGRANCE Henkel AG & Co. KGaA (DE) 2018-07-25 EP claimed
WO-2017207467-A1 METHOD OF RESOLVING ALLERGENS IN PERFUME INGREDIENTS GIVAUDAN SA (CH) 2017-12-07 WO claimed
EP-2395966-B1 COSMETIC COMPOSITION FOR SKIN CARE LENGHEIM HUBERT (AT) 2016-07-06 EP claimed
WO-2001079212-A1 SILICON DERIVATIVES OF FRAGRANT, FLAVOURING AND MEDICINAL SUBSTANCES KIREEV VYACHESLAV VASILIEVICH (RU) 2001-10-25 WO claimed
US-5696268-A REACTING N-ACYLAMINO ACID DERIVATIVE WITH OPTICALLY ACTIVE ENAMINE DERIVATIVE, REACTING PRODUCT WITH AMMONIA OR AMMONIUM SALT FUJIREBIO INC. (JP) 1997-12-09 US claimed
US-5644059-A REACTION OF KETONE WITH ACRYLAMIDE AND AMMONIA OR AMMONIUM SALT FUJIREBIO INC. (JP) 1997-07-01 US claimed
EP-0488345-A1 1,4-Dihydropyridine derivatives and methods of producing the same FUJIREBIO INC. (JP) 1992-06-03 EP claimed
US-20260102294-A1 ABSORBENT ARTICLE COMPRISING A FRAGRANCE AND AN ODOR CONTROL COMPOSITION PROCTER & GAMBLE (US) 2026-04-16 US disclosed
US-12577511-B2 Agent containing emulsifier and microcapsules HENKEL AG & CO. KGAA (DE) 2026-03-17 US disclosed
US-12543744-B2 Enhanced formulations, compositions and methods for pest control TYRATECH, INC. (US) 2026-02-10 US disclosed
EP-0400660-A1 1,4-dihydropyridine derivatives FUJIREBIO INC. (JP) 1990-12-05 EP disclosed
US-4672068-A Antihypertensive 1,4-dihydropyridines having a conjugated ester FUJIREBIO KABUSHIKI KAISHA (JP) 1987-06-09 US disclosed
EP-0161877-A2 1,4-dihydropyridine derivatives, methods for their production and pharmaceutical compositions comprising the same FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. (JP) 1985-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12577511-B2 Agent containing emulsifier and microcapsules LIPA, CUTA, MGLL PAM 4432/4885IDO1 2210/4885MAOB 1984/4885
US-20260102294-A1 ABSORBENT ARTICLE COMPRISING A FRAGRANCE AND AN ODOR CONTROL COMPOSITION CUTA, SHBG, DSG1 PAM 4593/4885IDO1 3359/4885MAOB 4455/4885
US-12543744-B2 Enhanced formulations, compositions and methods for pest control CASR, CALCR, PTMS PAM 3166/4885IDO1 3330/4885MAOB 4157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.